Clinical Trials Directory

Trials / Terminated

TerminatedNCT02995031

Sun Protection Factor Assay (318/2016)

Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Bayer · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

To evaluate the Sun Protection Factor efficacy on human skin.

Conditions

Interventions

TypeNameDescription
DRUGBAY987521Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application. (Formulation Code: Z09-177)
DRUGSPF ControlEach 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application.

Timeline

Start date
2017-01-03
Primary completion
2017-01-06
Completion
2017-01-06
First posted
2016-12-16
Last updated
2018-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02995031. Inclusion in this directory is not an endorsement.

Sun Protection Factor Assay (318/2016) (NCT02995031) · Clinical Trials Directory